The fact is, the largest PBMs continue to operate using a fundamentally flawed and disingenuous business model that prioritizes drug volume to fuel profits. It’s a model that is totally misaligned between the interests of the PBMs and the stakeholders they claim to serve, and pays short shrift to what truly matters, the health outcomes of patients and the long-term success of plan sponsors.
Danny Sanchez
Chief Executive Officer
Danny Sanchez is the Chief Executive Officer of EmpiRx Health, the leading clinically-driven pharmacy benefits management company. He is responsible for strengthening and expanding EmpiRx Health’s position as a driver of transformative change in the pharmacy benefits care industry. Danny leads the company’s mission to build and grow an innovative, high performance organization that puts the needs and interests of its customers first.
Danny’s career has been motivated by his belief that helping people access and adhere to the right therapies improves their health and impacts downstream costs. He brings 20+ years of healthcare technology experience to his role, along with a proven track record of developing and deploying innovative solutions that improve quality of care. He joined EmpiRx Health from Omnicell, where he held various leadership positions over his 16+ year tenure, and cultivated a focus on healthcare automation, patient adherence, and Population Health solutions. At Omnicell, he oversaw the launch of EnlivenHealth as General Manager, piloting numerous successful initiatives that harnessed technology to transform health and business outcomes.
His prior experience includes 3 years within the Medical Automation Division of McKesson Corporation. Danny holds degrees from Florida A&M University and from the H. Wayne Huizenga School of Business and Entrepreneurship at Nova Southeastern University.
